000 02197nam  2200385zi 4500
0019.895017
003CaOODSP
00520240917104214
006m     o  d f      
007cr cn|||||||||
008210104t20212021onc     o    f000 0 eng d
020 |a9780660370385
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-309/2021E-PDF
24500|aGuidance on summary reports and issue-related analyses for medical devices.
264 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2021.
264 4|c©2021
300 |a1 online resource (i, 11 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |aIssued also in HTML format.
500 |a"Publication date: January 2021."
500 |aIssued also in French under title: Lignes directrices sur les rapports de synthèse et les analyses liées à un sujet de préoccupation pour les instruments médicaux.
520 |a"This guidance document was prepared to help medical device manufacturers understand and comply with sections 25, 39 and 61.4 to 61.6 of the Medical Devices Regulations. Two new requirements in the Regulations were added to ensure the continued monitoring of benefits and risks after a product is authorized for sale in Canada"--Purpose of the guidance document, page 1.
650 0|aMedical instruments and apparatus|xSafety regulations|zCanada.
650 0|aMedical instruments and apparatus|xGovernment policy|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tLignes directrices sur les rapports de synthèse et les analyses liées à un sujet de préoccupation pour les instruments médicaux.|w(CaOODSP)9.895018
794 |tGuidance on summary reports and issue-related analyses for medical devices.|w(CaOODSP)9.943289
85640|qPDF|s688 KB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/H164-309-2021-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/medical-device-reports-analyses-guidance.html